From the Guidelines

Low-dose corticosteroids are not commonly used for interventional pain management procedures.

The studies provided do not specifically examine the use of low-dose (microgram) corticosteroids for interventional pain management procedures 1.
Instead, they focus on the use of systemic corticosteroids for low back pain and radiculopathy, with varying doses and treatment durations 1.
One study mentions the use of perineural glucocorticoids, such as betamethasone and dexamethasone, but notes that procedure-specific evidence is limited 1.

Systemic corticosteroids have been evaluated in several trials for low back pain and radiculopathy, but the evidence is inconsistent and generally shows no significant differences between corticosteroids and placebo 1.
The use of corticosteroids for interventional pain management procedures is not well-established, and more research is needed to determine their efficacy and safety in this context.

When considering the use of corticosteroids for pain management, it is essential to weigh the potential benefits against the risks of adverse effects, such as insomnia, nervousness, and increased appetite 1.
The evidence provided does not support the use of low-dose corticosteroids for interventional pain management procedures, and alternative treatments should be considered.

From the Research

The use of low-dose corticosteroids for interventional pain management procedures has been examined in several studies 2, 3, 4, 5.
A study published in 2020 found that there was no significant difference in the effectiveness of epidural injections with or without steroids, but noted a lack of evidence for peripheral intraarticular injections 2.
Another study published in 2008 reported a case of corticosteroid-induced psychosis in a patient who received multiple injections with corticosteroids, highlighting the potential side effects of corticosteroid use in interventional pain management 3.
A survey of pain medicine physicians found that there is a wide variation in practice regarding steroid administration, with 17% of respondents indicating that they administer steroids at intervals of less than 2 weeks, and 53% indicating that they wait 2-4 weeks between steroid doses 4.
A review of the literature on the use of corticosteroids for joint pain found that they provide moderate short-term benefit for reducing pain and improving functioning, but have multiple potential adverse effects, including toxicity to articular cartilage and systemic side effects such as increases in blood glucose levels and a reduction in immune function 5.

The evidence suggests that low-dose corticosteroids may be effective for short-term pain reduction and improvement in function, but have potential adverse effects that need to be considered 2, 5.
There is a need for evidence-based guidelines for the use of corticosteroids in interventional pain management to improve patient safety and minimize the risk of adverse events 4.
The use of corticosteroids in interventional pain management procedures should be carefully considered, taking into account the potential benefits and risks, as well as the individual patient's needs and medical history 2, 3, 5.